Cryoport (CYRX) announced the launch of its newest, state-of-the art facility in Louvres, France, through its subsidiary, Cryoport Systems. The facility, which is strategically located near the Paris Charles de Gaulle Airport, marks a strategic expansion of Cryoport Systems’ Global Supply Chain Center network, which offers end-to-end temperature-controlled supply chain solutions and capabilities. Purpose-built to streamline operations and address critical challenges in the advanced therapies market, the facility provides end-to-end, temperature-controlled supply chain solutions under one roof. As the third global supply chain center campus in Cryoport’s network, it will offer global accessibility for biopharma and other temperature-sensitive commodities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
- Cryoport price target raised to $15 from $10 at BTIG
- CryoPort’s Promising Future: Buy Rating Backed by Strong Financials and Growing C> Market
- CryoPort Delays 10-Q Filing Due to Compilation Challenges
- Cryoport Inc’s Earnings Call Highlights Growth and Optimism
- CryoPort’s Strong Q2 2025 Performance and Growth Prospects Justify Buy Rating